Inflammation and immunomodulatory therapies influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis
Related Posts
Aamir J, Afridi MK, Sajid M, Khan TM, Qureshi S, Ahmed R, Fonarow GC, Minhas AMK, Waqas SA. Obesity mortality on the rise: A 54-year[...]
Zhao G, Wu X, Huang S, Huang S, Zhang G, Zhou X, Cao S, Lim H, Duhon MI 2nd, Li R, Boström K, Li X.[...]
Yuan V, Lee K, Ambrosy AP, Ouyang D, Ieki H. Current State of Artificial Intelligence in Assessing Cardiac Function. Curr Cardiol Rep. 2025 Nov 27;27(1):158.[...]